Hemodynamic effects of antihypertensive therapy in patients with hypertension and rheumatoid arthritis comorbidity
https://doi.org/10.30629/0023-2149-2023-101-6-293-300
Abstract
Research objective. Evaluation of the influence of 6-month antihypertensive therapy with drugs of different classes on hemodynamic parameters of the circulatory system in patients with comorbid hypertension and rheumatoid arthritis. Materials and methods. Patients who met age criteria (58.6 ± 6.4 years), duration of hypertension (11.2 ± 1.6 years), onset (aged 45–64 years), and duration (7.2 ± 2.1 years) of rheumatoid arthritis were divided into groups: Group I (136 men, 141 women) — 277 patients with stage II hypertension; Group II (28 men, 114 women) — 142 patients with stage II hypertension and rheumatoid arthritis (in clinical-laboratory remission); Group III (20 men, 92 women) — 112 patients with stage II hypertension and rheumatoid arthritis (in clinical-laboratory exacerbation). Antihypertensive monotherapy was prescribed by polyclinic doctors: nebivolol, lisinopril, losartan, amlodipine, indapamide, and a combination of lisinopril and indapamide. Observation was carried out for 6 months. Results. The influence of antihypertensive therapy (6 months) on hemodynamic parameters of the circulatory system in patients of groups I and II was presented by positive dynamics of morphometric and speed parameters, while in group III patients the indicators were less significant and more distant. Conclusion. The presence of rheumatoid arthritis introduces additional changes in the dynamics of hemodynamic effects of prescribed antihypertensive therapy and is determined by the degree of disease activity and adequacy of basic anti-inflammatory therapy.
About the Authors
N. A. Samorodskaya
Kuban State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Natalia A. Samorodskaya.
350063, Krasnodar
L. N. Eliseeva
Kuban State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Lyudmila N. Eliseeva.
350063, Krasnodar
References
1. Vicente G.N., Pereira I.A., Castro R.W. Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of antirheumatic drugs: a cross-sectional real-life study. Advances in Rheumatology. 2021;61(1):38–40. DOI: 10.1186/s42358-021-00186-4
2. Fomicheva O.A., Popkova T.V., Krougly L.B., Gerasimova E.V., Novikova D.S., Pogorelova O.A., Tripoten M.I., Balakhonova T.V., Karpov Yu.A., Nasonov E.L. Factors of progression and occurrence of atherosclerosis in rheumatoid arthritis. Kardiologiia. 2021;61(1):12–21. (In Russian). DOI: 10.18087/cardio.2021.1.n1331
3. Wilson J.C., Sarsour K., Gale S., Pethö-Schramm A., Jick S.S., Meier C.R. Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis. Arthritis Care Res. 2019;71(4):498–511. DOI: 10.1002/acr.23611
4. Nasonov E.L. Pharmacotherapy for rheumatoid arthritis: New strategy, new targets. Nauchno-prakticheskaya revmatologiya. 2017;55(4):409–419. (In Russian). DOI:10.14412/1995-4484-2017-409-419
5. Nasonov EL, Karateev DE, Chichasova NV. New recommendations for the management of rheumatoid arthritis (EULAR, 2013): the role of methotrexate. Nauchno-prakticheskaya revmatologiya. 2014;52(1):8–26. (In Russian). DOI: 10.14412/1995-4484-2014-8-26
6. Stryuk R.I., Brytkova Y.V., Tatarinova O.V. Mono- or combined antihypertensive therapy in women with arterial hypertension and moderate risk of cardiovascular diseases: what’s better? Meditsinskiy sovet. 2017;(20):40–44. (In Russian). DOI: 10.21518/2079-701X-2017-20-40-44
7. Kotolupova O.V., Kryuchkova O.N. Specifics of daily blood pressure monitoring in patients with systemic hypertension and obstructive sleep apnoea: a case-control study. Kubanskij nauchnyj medicinskij vestnik. 2022;29(2):45–57. (In Russian). DOI: 10.25207/1608-6228-2022-29-2-45-57
8. Gorbunov V.M., Karpov Yu.A., Platonova E.V., Koshelyaevskaya Y.N. Twenty-four-hour and office blood pressure measurement in a comprehensive assessment of the effectiveness of 12-week therapy with a triple fixed-dose combination of amlodipine/indapamide/perindopril in hypertensive patients in actual clinical practice. Rossijskij kardiologicheskij zhurnal. 2021;26(5):44–98. (In Russian). DOI: 10.15829/1560-4071-2021-4498
9. Oranskiy S.P., Yeliseyeva L.N., Kurinnaya V.P., Davydova A.F. Kidney injury in rheumatoid arthritis: relationship with cardiovascular risk factors. Nefrologija. 2017;21(5):42–47. (In Russian). DOI: 10.24884/1561-6274-2017-21-5-44-53
10. Nikitina N.M., Romanova T.A., Rebrov A.P. Blood pressure ambulatory monitoring as a method for early hypertension diagnostics in rheumatoid arthritis patients. Rossijskij kardiologicheskij zhurnal. 2017;4(144):29–34. (In Russian). DOI: 10.15829/1560-4071-2017-4-29-34
11. Panoulas V.F., Douglas K.M.J., Milionis H.J., Stavropoulos-Kalinglou A., Nightingale P., Kita M.D., Tselios A.L., Metsios G.S., Elisaf M.S., Kitas G.D. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford). 2007;46(9):1477–82. DOI: 10.1093/rheumatology/kem169
12. Karateev A.E. Destabilized hypertension as a complication of therapy with nonsteroidal anti-inflammatory drugs: the importance of the problem. Sovremennaya revmatologiya. 2018;2(12):64–72. (In Russian). DOI: 10.14412/1996-7012-2018-2-64-72
13. Ostroumova О.D., Kochetkov А.I., Lopukhina М.V., Pavleeva Е.Е. High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression. Rossijskij kardiologicheskij zhurnal. 2018;(9):77–88. (In Russian). DOI: 10.15829/1560-4071-2018-9-77-88
14. Möller B., Pruijm M., Adler S. Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis. 2015;74(4):718–23. DOI: 10.1136/annrheumdis2013-204078
15. Boers M., Croonen A.M., Dijkmans B.A. Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis. 1987;46:658–63. DOI: 10.1136/ard.46.9.658
Review
For citations:
Samorodskaya N.A., Eliseeva L.N. Hemodynamic effects of antihypertensive therapy in patients with hypertension and rheumatoid arthritis comorbidity. Clinical Medicine (Russian Journal). 2023;101(6):293-300. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-6-293-300
Views:
438
Email this article 